Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GELS
GELS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GELS News
Gelteq Limited Reports Clinical and Commercial Milestones for H1 2026
3d ago
Newsfilter
Gelteq Completes Successful Veterinary Palatability Trials
Jun 12 2026
Newsfilter
Biotech Companies See Significant Stock Gains
Jun 12 2026
NASDAQ.COM
Gelteq Establishes Center of Excellence in Guangdong, China
Jun 04 2026
Newsfilter
Gelteq Initiates First Clinical Trial for Veterinary Drug Candidate
May 20 2026
Newsfilter
Gelteq Secures $3.5 Million Debt Financing for Growth
May 12 2026
seekingalpha
Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%
Jan 14 2026
Benzinga
U.S. Stock Futures Decline as CPI Rises 2.7% Year Over Year
Jan 14 2026
Benzinga
Bank of America Expected to Report $0.96 EPS on $27.87 Billion Revenue
Jan 14 2026
Benzinga
Gelteq Ltd. (NASDAQ:GELS) Shares Surge 69.25% on Positive Preclinical Results
Jan 14 2026
Benzinga
Gelteq Partners with Hong Kong Flag Football Program, Secures $1.3M Annual Revenue Commitment
Dec 16 2025
Globenewswire
Gelteq Partners with Hong Kong Flag Football Program, Securing $1.3M Annual Revenue
Dec 16 2025
Newsfilter
Gelteq Enters 3-Year Sales Agreement with Mana, Projecting $1.3M Revenue
Dec 09 2025
Globenewswire
Gelteq's Novel Oral Delivery System Significantly Enhances Bioavailability
Dec 05 2025
Globenewswire
Gelteq Reports 38-45% Bioavailability Increase in New Antihistamine Gel Formulation
Nov 24 2025
Newsfilter
Gelteq Partners with Melbourne Health to Develop Innovative Compound for Reducing Bowel Polyp Growth
Oct 09 2025
Newsfilter
Show More News
